156 related articles for article (PubMed ID: 21645022)
21. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging.
Murata T; Dohi K; Onishi K; Sugiura E; Fujimoto N; Ichikawa K; Ishikawa E; Nakamura M; Nomura S; Takeuchi H; Nobori T; Ito M
Nephrol Dial Transplant; 2011 May; 26(5):1655-61. PubMed ID: 20864553
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
23. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
[TBL] [Abstract][Full Text] [Related]
24. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
[TBL] [Abstract][Full Text] [Related]
26. Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma.
Jaracz J; Kucharska A; Rajewska-Rager A; Lacka K
J Endocrinol Invest; 2012 Sep; 35(8):760-5. PubMed ID: 21986400
[TBL] [Abstract][Full Text] [Related]
27. Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma.
Shargorodsky M; Serov S; Gavish D; Leibovitz E; Harpaz D; Zimlichman R
Thyroid; 2006 Apr; 16(4):381-6. PubMed ID: 16646685
[TBL] [Abstract][Full Text] [Related]
28. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
29. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
[TBL] [Abstract][Full Text] [Related]
30. A high-normal thyrotropin level is associated with the severity of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Chen S; Yuan J; Qiao S; Tian Y; Duan F; Hu F; Yang W; Zhou C; Yang X; Yang Y
Kardiol Pol; 2013; 71(2):143-51. PubMed ID: 23575707
[TBL] [Abstract][Full Text] [Related]
31. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
32. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
[TBL] [Abstract][Full Text] [Related]
33. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.
Mercuro G; Panzuto MG; Bina A; Leo M; Cabula R; Petrini L; Pigliaru F; Mariotti S
J Clin Endocrinol Metab; 2000 Jan; 85(1):159-64. PubMed ID: 10634380
[TBL] [Abstract][Full Text] [Related]
34. Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.
Casu M; Cappi C; Patrone V; Repetto E; Giusti M; Minuto F; Murialdo G
Eur J Endocrinol; 2005 Jun; 152(6):819-24. PubMed ID: 15941920
[TBL] [Abstract][Full Text] [Related]
35. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
[TBL] [Abstract][Full Text] [Related]
36. Thyroid function and left ventricular structure and function in the Framingham Heart Study.
Pearce EN; Yang Q; Benjamin EJ; Aragam J; Vasan RS
Thyroid; 2010 Apr; 20(4):369-73. PubMed ID: 20210671
[TBL] [Abstract][Full Text] [Related]
37. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
[TBL] [Abstract][Full Text] [Related]
38. Left ventricular strain and strain rate by two-dimensional speckle tracking echocardiography in patients with subclinical hypothyroidism.
Sunbul M; Durmus E; Kivrak T; Yildiz H; Kanar BG; Ozben B; Sari I; Mutlu B
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3323-8. PubMed ID: 24379063
[TBL] [Abstract][Full Text] [Related]
39. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine.
Shapiro LE; Sievert R; Ong L; Ocampo EL; Chance RA; Lee M; Nanna M; Ferrick K; Surks MI
J Clin Endocrinol Metab; 1997 Aug; 82(8):2592-5. PubMed ID: 9253339
[TBL] [Abstract][Full Text] [Related]
40. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
